SOURCE: CDEX, Inc.

January 09, 2008 09:15 ET

CDEX to Demonstrate the Methamphetamine Scanner™ at the ASHI Inspection World Conference in New Orleans January 16-19, 2008

Exposure to "Second-Hand Methamphetamine" Left in Houses, Apartments and Hotel Rooms Can Result in Devastating Health and Economic Consequences. The CDEX Meth Scanner™ Detects Meth Down to the Low Nanogram Range

TUCSON, AZ--(Marketwire - January 9, 2008) - CDEX, Inc. (OTCBB: CEXI) will demonstrate the Meth Scanner™ at the ASHI Inspection World Conference in New Orleans, Louisiana January 16-19, 2008. Inspection World is the largest annual professional gathering for Home Inspectors in the United States. The health impact of moving into a meth contaminated house, apartment or hotel room can be tragic, particularly for children. Moreover, the unsuspecting new homeowner or mortgage lender is often burdened with a massive cleanup cost. Now in a 5-10 minute, low cost add-on to a routine home inspection, a Property Inspector using the Meth Scanner can give the prospective homeowner an instantaneous answer -- "Meth Clean" or "Stay Away!"

The CDEX ID2 ("Meth Scanner") is a handheld, battery-operated device that detects low nanogram range quantities of methamphetamine in a continuous scan mode from standoff distances of 2-8 inches. The Meth Scanner gives instantaneous results requiring no operator interpretation without disturbing the surfaces under investigation. Meth Scanner technology is used in the CDEX ValiMed™ Medication Validation System currently deployed in major hospitals across the United States. (See www.cdex-inc.com or www.valimed.com)

About CDEX, Inc.

CDEX, a technology development company currently developing products using its patented/patent pending chemical detection technologies, is focused on (i) identification of substances of concern (e.g., explosives and illegal drugs, for security markets); and (ii) validation of substances for anti-counterfeiting, brand protection and quality assurance (e.g., validation of compounded medication and detection of counterfeit or sub-par products, for the medical and brand protection markets). ValiMed™ and the Meth Scanner™ are CDEX solutions for the healthcare and security markets. Corporate headquarters and R&D facilities are located in Tucson, Arizona. For more information, visit www.cdex-inc.com and www.valimed.com or contact Malcolm Philips (mphilips@cdex-inc.com) or Tim Shriver, Jr. (tshriverjr@cdex-inc.com) at 520.745.5172 X 210 or 201.

Any Non-Historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other similar words. These statements pose risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the Protection of intellectual property and proprietary information, and other risks detailed from time to time in filings with the SEC. There is no obligation to publicly update any forward-looking statements.

Contact Information